In a significant ruling, the Supreme Court has sided with Bayer in its ongoing litigation over the popular weedkiller Roundup, blocking thousands of lawsuits claiming the product causes cancer. This decision has raised concerns about the gap between legal rulings and scientific evidence regarding the health risks of glyphosate, the active ingredient in Roundup. Opponents, including various advocacy groups, have expressed their disappointment, claiming the ruling undermines consumer protections and limits the rights of individuals affected by the weedkiller. Bayer’s stock has surged following the decision, which many see as a pivotal moment for the company amidst ongoing discussions about the safety of pesticides and their labeling.